Selectivity of a series of clonidine-like drugs for alpha 1 and alpha 2 adrenoceptors in rat brain.
D000814:Aniline Compounds / Q000494:pharmacology; D000818:Animals; D002540:Cerebral Cortex / Q000187:drug effects*; D003000:Clonidine / Q000031:analogs & derivatives / Q000494:pharmacology; D006143:Guanabenz / Q000494:pharmacology; D016316:Guanfacine; D006146:Guanidines / Q000494:pharmacology*; D007093:Imidazoles / Q000494:pharmacology*; D066298:In Vitro Techniques; D007217:Indoramin / Q000494:pharmacology; D009278:Naphazoline / Q000494:pharmacology; D010080:Oxazoles / Q000494:pharmacology; D010648:Phenylacetates / Q000494:pharmacology; D011224:Prazosin / Q000494:pharmacology; D051381:Rats; D011941:Receptors, Adrenergic / Q000187:drug effects*; D011942:Receptors, Adrenergic, alpha / Q000187:drug effects*; D013329:Structure-Activity Relationship; D013876:Thiophenes / Q000494:pharmacology; D014052:Toluidines / Q000494:pharmacology
D000814:Aniline Compounds; D006146:Guanidines; D007093:Imidazoles; D010080:Oxazoles; D010648:Phenylacetates; D011941:Receptors, Adrenergic; D011942:Receptors, Adrenergic, alpha; D013876:Thiophenes; D014052:Toluidines; D007217:Indoramin; C010354:tiamenidine; C003822:BAY-a 6781; D016316:Guanfacine; C011266:ST 91; D006143:Guanabenz; D009278:Naphazoline; D003000:Clonidine; C025655:lofexidine; D011224:Prazosin; C010227:flutonidine